Gyroscope Therapeutics’ $148.0 Million Series C Equity Financing

Davis Polk advised Gyroscope Therapeutics Limited on the deal.Gyroscope Therapeutics Limited executed its $148 million private placement of Series C preferred shares. The financing was led…